
Phreesia Faces Class Action Over Alleged Revenue Projection Failures
A federal class action lawsuit has been filed against Phreesia, Inc., accusing the healthcare technology firm of misleading investors regarding the stability of its pharmaceutical marketing commitments. The litigation follows a sharp 27% decline in share price triggered by a significant reduction in the company's fiscal 2027 revenue guidance.
























